Approved in France since the end of July by the High Authority for Health for adolescents aged 12 to 17, Moderna's anti-Covid vaccine has just been suspended for those under 30 in Sweden.
This decision comes "after signs of increased risk of side effects such as inflammation of the myocardium and pericardium" in young people, specifies the public health authority (FHM), in charge of the vaccination campaign, evoking a "pause" by "precautionary principle".
According to the agency, the risk is greater after the second dose of Moderna Spikevax and in males.
“But the risk of being affected is minimal, it is a very rare side effect,” she emphasizes.
"Myocarditis and pericarditis often go away on their own, without causing lasting problems, but symptoms should be evaluated by a doctor," the agency explains.
About 81,000 people under the age of 30 received a first dose of Moderna in Sweden and not the second.
The European Medicines Agency in July extended its authorization of the Moderna vaccine to 12-17 year olds.
Coronavirus: Chinese vaccines partly recognized for the health pass
Coronavirus: Moderna's vaccine would be the most effective against severe forms over time